We are live on ! Find out more
NVNO icon

enVVeno Medical

26 hedge funds and large institutions have $17.3M invested in enVVeno Medical in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,229% more call options, than puts

Call options by funds: $1.64M | Put options by funds: $38K

14% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 7

2.68% less ownership

Funds ownership: 27.36% → 24.68% (-2.7%)

16% less funds holding

Funds holding: 31 → 26 (-5)

50% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 8

78% less capital inflows, than outflows

Capital inflows: $473K | Capital outflows: $2.17M

Holders
26
Holders Change
-5
Holders Change %
-16.13%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
8
Reduced
7
Closed
8
Calls
$1.64​M
Puts
$38​K
Net Calls
+$1.61​M
Net Calls Change
-⁠$2.3​M

NVNO Hedge Fund Activity: Q2 2024 in Review

26 of the 6,946 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q2 2024, worth a combined $17.3M — down 13% from $19.8M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of NVNO and 4 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 8 added.

The largest buyer was Westside Investment Management, adding an estimated $175K. The largest seller was Velan Capital Investment Management, exiting entirely with an estimated $937K sold.

  • 26 institutional investors held enVVeno Medical (NVNO) as of Q2 2024, down from 31 in Q1 2024.
  • Funds reported $17.3M of enVVeno Medical stock for Q2 2024, down 13% quarter-over-quarter.
  • 4 funds opened new enVVeno Medical positions in Q2 2024 and 8 closed out, a net change of -4 holders.
  • The largest enVVeno Medical buyer in Q2 2024 was Westside Investment Management, an estimated $175K added.
  • The largest enVVeno Medical seller in Q2 2024 was Velan Capital Investment Management, an estimated $937K sold.

Based on aggregated 13F filings for Q2 2024.